These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Retention time of colloid-osmotic infusions]. Halmágyi M Beitr Infusionther Klin Ernahr; 1979; 2():51-68. PubMed ID: 94261 [No Abstract] [Full Text] [Related]
4. Intravascular retention, dispersal, excretion and break-down of gelatin plasma substitutes. Zekorn D Bibl Haematol; 1969; 33():131-40. PubMed ID: 5383986 [No Abstract] [Full Text] [Related]
5. [Behavior of hydroxyethyl starch in the plasma and urine of man following intravenous infusion]. Oda A; Aoki A; Ozaki T; Unno K; Nagai N Masui; 1972 Aug; 21(8):747-53. PubMed ID: 4674920 [No Abstract] [Full Text] [Related]
8. A study of the mastocytolytic effects of polycations in the presence of certain plasma substitutes. Keller R Bibl Haematol; 1969; 33():126-30. PubMed ID: 4193927 [No Abstract] [Full Text] [Related]
9. The hydroethylated amylopectins. Model substances comprising a two-variable system for the design of specific-acting volaemic colloids. Mishler JM Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):67-72. PubMed ID: 7372378 [TBL] [Abstract][Full Text] [Related]
10. Hydroxyethyl starch as a plasma expander in hemorrhagic shock. Murray GF; Solanke T; Thompson WL; Ballinger WF Surg Forum; 1965; 16():34-5. PubMed ID: 5835186 [No Abstract] [Full Text] [Related]
11. [Effect of kidney function on the elimination and action of colloidal plasma substitutes]. Köhler H Fortschr Med; 1979 Oct; 97(40):1809-13. PubMed ID: 94298 [TBL] [Abstract][Full Text] [Related]
12. Changes in the molecular composition of circulating hydroxyethyl starch. Farrow SP; Hall M; Ricketts CR Br J Pharmacol; 1970 Apr; 38(4):725-30. PubMed ID: 5441787 [TBL] [Abstract][Full Text] [Related]
13. The effects of a new plasma expander (hydroxyethyl starch) on intravascular clot formation. Arrants JE; Cooper N; Lee WH Am Surg; 1969 Jul; 35(7):465-7. PubMed ID: 5785906 [No Abstract] [Full Text] [Related]
14. [Storing of plasma expanders in the reticuloendothelial system]. Sonntag W; Paulini K Verh Dtsch Ges Pathol; 1978; 62():346. PubMed ID: 85388 [No Abstract] [Full Text] [Related]
15. Comparison of hydroxyethyl starch with plasma and dextrans in severe haemodilution. Takaori M; Safar P; Galla SJ Can Anaesth Soc J; 1968 Jul; 15(4):347-56. PubMed ID: 5661386 [No Abstract] [Full Text] [Related]
16. The renal effects of acute hemodilution with hydroxyethyl starch, dextran, or saline. Murphy GP Surg Gynecol Obstet; 1965 Dec; 121(6):1325-33. PubMed ID: 5851627 [No Abstract] [Full Text] [Related]
17. Studies on the distribution and excretion of Haemaccel in man. Schwartzkopff W Bibl Haematol; 1969; 33():141-51. PubMed ID: 5383987 [No Abstract] [Full Text] [Related]
18. [On excretion of the plasma substitute solution "zhelatinol"]. Znamenskaia TV Probl Gematol Pereliv Krovi; 1966 Jul; 11(7):37-42. PubMed ID: 6002179 [No Abstract] [Full Text] [Related]
19. Studies on hydroxyethyl starch as a plasma expander. II. Influences of molecular weight of hydroxyethyl starch on its physicochemical and biological properties. Tamada T; Okada K; Ishida R; Kamishita K; Irikura T Chem Pharm Bull (Tokyo); 1971 Feb; 19(2):286-91. PubMed ID: 5549054 [No Abstract] [Full Text] [Related]
20. Preliminary report on the use of hydroxyethyl starch solution in man. Ballinger WF; Murray GF; Morse EE J Surg Res; 1966 Apr; 6(4):180-3. PubMed ID: 5906918 [No Abstract] [Full Text] [Related] [Next] [New Search]